United States · Pharmaceuticals startup
United States · Amplyx Pharmaceuticals
Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems
Funding reportedLast round: Series C
What company datasets say Amplyx Pharmaceuticals raised
Funding, as reported
Reported in all$198Min dollars
Rounds9
Last roundSeries C
Last round dateMay 2020
Investors listed14
SEC Form D$177M sold, 5 filings, last Jan 2020
Founders and team
From the SEC filings it signed: 3 on the team.
- Alan FuhrmanExecutive Officeri
- Ciara KennedyExecutive Officer, Directori
- Mike HodgesExecutive Officeri
On the board, as filediAnand MehraEdward MathersElaine HeronJohan KordelMichael GreyNiall ODonnellPaul Grint
Pharmaceuticals in United States
Startups like it
AMAG PharmaceuticalsWaltham · founded 1981- PL DevelopmentsWestbury · founded 1988
Remedi SeniorCareBaltimore · founded 1954- Spectrum PharmaceuticalsLake Forest · founded 1987
- moksha8 PharmaceuticalsBerwyn · founded 2007
NeurelisSan Diego · founded 2007- Zosano PharmaFremont · founded 2006
Alexza PharmaceuticalsFremont · founded 2001
Is this your company?
Add your raise, your deck and your story, and put Amplyx Pharmaceuticals in front of investors. Or tell us what we have wrong.